-
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Yesterday & Today
A Leading LadyBetty Ford's candor about her breast cancer diagnosis helped bring a private issue out of the shadows.
by Corinna Wu
-
In the Moment- Fall 2012
Pamela Clark, Emily-Kate Niskey, Loretta Cox, Tim Buckland
-
Yesterday & Today
A Touch of MagicElizabeth Montgomery led a bewitching life that was cut short by colorectal cancer in 1995.
by Sue Rochman
-
Survivor Profile
Spreading the WordAn African-American banking pioneer finds fulfillment in increasing prostate cancer awareness.
by Yvonne Lee
-
In the Moment- Summer 2012
Evelyn Reyes, Sarah Dees, Greg Cantwell, Patrick Gavin.
-
The Survival Gap
In the Nowhere Land between adult and pediatric cancer treatment, young adults face survival rates that have missed out on the gains seen by other age groups. Can new efforts help them improve their outcomes?
by Charlotte Huff
-
Yesterday & Today
Alec Guinness, Reluctant Intergalactic IconLiver cancer took the legendary actor and his wife of 62 years just months apart. Twelve years later, where do efforts to prevent and treat the disease stand?
by Jocelyn Selim
-
In the Moment- Spring 2012
Todd Spurrier, Barry Haigis, Marianthy Karantzes, Rebecca Casciato
-
Survivor Profile
When Cancer Meets Inner DriveDiagnosed at 28, Rochelle Shoretz has stayed true to her big dreams and to her goal of helping other young women with breast cancer.
by Yvonne Lee
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff